Literature DB >> 22158873

Interleukin (IL)-23 suppresses IL-10 in inflammatory bowel disease.

Zhanju Liu1, Bai-Sui Feng, Shao-Bo Yang, Xiao Chen, Jingling Su, Ping-Chang Yang.   

Abstract

Interleukin (IL)-10 plays an important role in immune regulation in the intestine. Immune deregulation is suggested in the pathogenesis of inflammatory bowel disease (IBD). This study aims to elucidate the role of IL-23 in the suppression of IL-10 in the IBD intestinal mucosa. Surgically removed colon specimens were obtained from 16 IBD patients. The expressions of IL-10, IL-23, and IgA in the specimens were examined at the protein and gene transcriptional levels. The gene transcription of IL-10 was assessed by chromatin immunoprecipitation assay and promoter accessibility assay. The levels of IgA and IL-10 were significantly lower, whereas the levels of IL-23 were higher, in IBD specimens than in normal controls. The levels of IgA and IL-10 were negatively correlated with the infiltration of inflammatory cells in the IBD mucosa. The production of IL-10 by lamina propria mononuclear cells was lower in the IBD group than in the control group, and these levels could be enhanced by blocking IL-23. The gene transcription of IL-10 was significantly suppressed in CD4(+) T cells of IBD mucosa; this phenomenon could be replicated in vitro by adding IL-23 in the culture of polarized Th2 cells. Overexpression of IL-23 in the intestinal mucosa suppresses the production of IL-10, which weakens the defensive barrier by reducing the production of IgA in the gut.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158873      PMCID: PMC3271012          DOI: 10.1074/jbc.M111.304949

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene.

Authors:  S Rao; E Procko; M F Shannon
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

2.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

3.  Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria.

Authors:  Andrew J Macpherson; Therese Uhr
Journal:  Science       Date:  2004-03-12       Impact factor: 47.728

Review 4.  Inflammatory bowel disease (1)

Authors:  D K Podolsky
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

5.  Possible involvement of IL-21 and IL-10 on salivary IgA levels in chronic periodontitis subjects.

Authors:  M H Napimoga; L H A C Nunes; A A B Maciel; A P D Demasi; B B Benatti; V R Santos; M F Bastos; T S de Miranda; P M Duarte
Journal:  Scand J Immunol       Date:  2011-12       Impact factor: 3.487

6.  Complexes between nuclear factor-κB p65 and signal transducer and activator of transcription 3 are key actors in inducing activation-induced cytidine deaminase expression and immunoglobulin A production in CD40L plus interleukin-10-treated human blood B cells.

Authors:  S Lafarge; H Hamzeh-Cognasse; Y Richard; B Pozzetto; M Cogné; F Cognasse; O Garraud
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

Review 7.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.

Authors:  Warren Strober; Ivan J Fuss
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

8.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

9.  Antigen-specific secretory IgA antibodies in the gut are decreased in a mouse model of food allergy.

Authors:  Christophe P Frossard; Conrad Hauser; Philippe A Eigenmann
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

10.  IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.

Authors:  Alessandra Geremia; Carolina V Arancibia-Cárcamo; Myles P P Fleming; Nigel Rust; Baljit Singh; Neil J Mortensen; Simon P L Travis; Fiona Powrie
Journal:  J Exp Med       Date:  2011-05-16       Impact factor: 14.307

View more
  19 in total

1.  Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration.

Authors:  Jingling Su; Chenxi Xie; Yanyun Fan; Weizi Cheng; Yiqun Hu; Qingwen Huang; Huaxiu Shi; Lin Wang; Jianlin Ren
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Regulatory immune cells in regulation of intestinal inflammatory response to microbiota.

Authors:  M Sun; C He; Y Cong; Z Liu
Journal:  Mucosal Immunol       Date:  2015-06-17       Impact factor: 7.313

Review 3.  The Role of Vitamin D in Immune System and Inflammatory Bowel Disease.

Authors:  Zengrong Wu; Deliang Liu; Feihong Deng
Journal:  J Inflamm Res       Date:  2022-05-28

4.  Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice.

Authors:  Hanying Zhang; Yansong Xue; Hui Wang; Yan Huang; Min Du; Qiyuan Yang; Mei-Jun Zhu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

5.  A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.

Authors:  Vivian Zhou; Kimberle Agle; Xiao Chen; Amy Beres; Richard Komorowski; Ludovic Belle; Carolyn Taylor; Fenlu Zhu; Dipica Haribhai; Calvin B Williams; James Verbsky; Wendy Blumenschein; Svetlana Sadekova; Eddie Bowman; Christie Ballantyne; Casey Weaver; David A Serody; Benjamin Vincent; Jonathan Serody; Daniel J Cua; William R Drobyski
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

6.  Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.

Authors:  C Liu; X Xia; W Wu; R Wu; M Tang; T Chen; F Xu; Y Cong; X Xu; Z Liu
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

7.  Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.

Authors:  Weizi Cheng; Jingling Su; Yiqun Hu; Qingwen Huang; Huaxiu Shi; Lin Wang; Jianlin Ren
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

Review 8.  Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.

Authors:  Xiao-Rong Xu; Chang-Qin Liu; Bai-Sui Feng; Zhan-Ju Liu
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

9.  A novel pathway by which the environmental toxin 4-Nonylphenol may promote an inflammatory response in inflammatory bowel disease.

Authors:  Albert Kim; Byeong Ho Jung; Patrick Cadet
Journal:  Med Sci Monit Basic Res       Date:  2014-04-10

10.  Infliximab preferentially induces clinical remission and mucosal healing in short course Crohn's disease with luminal lesions through balancing abnormal immune response in gut mucosa.

Authors:  Lijuan Yu; Xuehua Yang; Lu Xia; Jie Zhong; Wensong Ge; Jianxin Wu; Hongchun Liu; Fei Liu; Zhanju Liu
Journal:  Mediators Inflamm       Date:  2015-03-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.